Opioid Maintenance Therapy: A Review of Methadone, Buprenorphine, and Naltrexone Treatments for Opioid Use Disorder.
Semin Neurol
; 44(4): 441-451, 2024 Aug.
Article
en En
| MEDLINE
| ID: mdl-38848746
ABSTRACT
The rates of opioid use and opioid related deaths are escalating in the United States. Despite this, evidence-based treatments for Opioid Use Disorder are underutilized. There are three medications FDA approved for treatment of Opioid Use Disorder Methadone, Buprenorphine, and Naltrexone. This article reviews the history, criteria, and mechanisms associated with Opioid Use Disorder. Pertinent pharmacology considerations, treatment strategies, efficacy, safety, and challenges of Methadone, Buprenorphine, and Naltrexone are outlined. Lastly, a practical decision making algorithm is discussed to address pertinent psychiatric and medical comorbidities when prescribing pharmacology for Opioid Use Disorder.
Texto completo:
1
Colección:
01-internacional
Banco de datos:
MEDLINE
Asunto principal:
Buprenorfina
/
Tratamiento de Sustitución de Opiáceos
/
Metadona
/
Naltrexona
/
Antagonistas de Narcóticos
/
Trastornos Relacionados con Opioides
Límite:
Humans
Idioma:
En
Revista:
Semin Neurol
/
Semin. neurol
/
Seminars in neurology
Año:
2024
Tipo del documento:
Article